Boundless Bio (BOLD) announced that Robert Doebele, M.D., Ph.D., has been appointed as Chief Medical Officer. Doebele was the co-founder of Rain Oncology, a precision oncology company, where he served as Chief Scientific and Medical Officer, directing the research and development of innovative therapies targeting oncogenic drivers in tumor-agnostic, biomarker-driven trials
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOLD: